Ginseng is a world-famous traditional Chinese medicine. As early as 4000 years ago, our ancestors used ginseng to prevent and treat diseases. In the early 1990s, Japanese scholar Kitagawa Xun found that Ginsenoside Rg3, an active substance in ginseng, can selectively inhibit the infiltration and metastasis of tumor cells. Ginsenoside Rg3 is not a component of natural ginseng, but a derivative and compound of processed ginseng.
Ginsenoside Rg3 is the most active natural biological component extracted from red ginseng. It is recognized as a "protein energy synthesis promoting factor" by modern medicine. The main reason is that Ginsenoside Rg3 can directly act on the cell reproductive cycle, express multiple gene networks in many systems of regulation, defense, repair and metabolism, enhance energy metabolism, enhance nucleic acid and protein synthesis, optimize molecular structure and biochemical process, promote the dynamic balance of protein synthesis and degradation (speed), remove conjugated products (body garbage, including fatigue toxins), inhibit pathological cells, activate decaying cells, repair damaged cells, so as to achieve anti fatigue, anti-aging, anti pathological, anti-cancer and anti-cancer, and deeply mobilize the vitality of the body.
Experiments and clinical treatment practice have proved that Ginsenoside Rg3 has definite anti-tumor effect. Tumors develop through several stages. Ginsenoside Rg3 can inhibit the proliferation of tumor cells, mainly in G2 phase. It can effectively inhibit the synthesis of pre mitotic protein and ATP of tumor cells, selectively inhibit the invasion and metastasis of tumor cells, inhibit tumor angiogenesis, and inhibit the proliferation, invasion, metastasis and recurrence of tumor cells. At the same time, Rg3 can promote phagocytosis, increase the content of immune protein in blood, improve the level of T cell subpopulation, activate NK cells, improve human immune function and enhance anti-tumor function. A large number of experiments have shown that Ginsenoside Rg3 can inhibit liver cancer by 98.8%, colon cancer by 89.0%, small cell lung cancer by 90.0% and pancreatic cancer by 89.0%.
It is particularly worth mentioning thatGinsenoside Rg3It has no side effects on normal cells. If applied in combination with chemotherapy and radiotherapy, it can increase leukocytes, improve liver function, enhance lymphocyte transformation ability, improve symptoms, and prolong survival time. It is promising for cancer treatment.